2022 North America Virology, Bacteriology, Parasitology and Mycology Market Size, Shares and Forecasts

This unique report provides data and analysis not available from any other published source, including test volume and sales forecasts for 100 individual tests, and competitor strategies. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies.

The report is available by section, and can be customized to specific information needs and budget.

The report provides granular market segmentation analysis and forecasts for over 100 microbiology tests; profiles leading suppliers and recent market entrants with innovative technologies and products; reviews current instrumentation; evaluates emerging technologies; and offers specific opportunities and strategies for suppliers.

Rationale

This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies.

The infectious disease testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces is continuing spread of AIDS, which remains the world’s major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs. Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Carbapenemase, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes, Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, Norovirus, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Country Analyses

Canada, Mexico, US

Market Segmentation Analysis

- Sales and market shares of major suppliers of
infectious disease diagnostic products in major countries by test.

- Test and sales forecasts for 100 infectious disease diagnostic
assays by country, individual test and market segment:

- Review of market dynamics, trends,
structure, size, growth and major suppliers.

Current and Emerging Products

- In-depth examination of major diseases,
including their etiology, current diagnostic tests,
vaccines, drugs and market needs.

- Review of major analyzers used for infectious disease
testing, including their operating
characteristics, features and selling prices.

Technology Review

- Assessment of emerging diagnostic technologies and their potential
applications for infectious disease testing.

- Companies developing or
marketing infectious disease diagnostic products
by individual test.

Competitive Assessments

- Strategic assessments of major suppliers and
emerging market entrants, including their sales, product
portfolios, marketing tactics, collaborative
arrangements and new products in R&D.

Opportunities and Strategies for Suppliers

- Emerging opportunities for new instrumentation,
reagent systems, IT and other products with significant market
appeal during the next five years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

I. Introduction
II. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
III. Design Criteria for Decentralized Testing Products
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. Overview of Major Tests,
Technologies and Instrumentation
A. Major Infectious Disease Tests
1. AIDS: HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
2. Adenovirus
3. Aeromonas
4. Anthrax/Bacillus Anthracis
5. Arboviruses
6. Babesiosis
7. Bacillary Epithelioid Angiomatosis (BEA) and Other Bartonella (Rochalimaea)
8. Blastocystis Hominis
9. Brucella
10. Campylobacter
11. Candida
12. Carbapenemase
13. Chagas Disease
14. Chancroid
15. Chlamydia
Table of Contents (continued)
16. Clostridium Difficile
17. Coronaviruses
18. Coxsackieviruses
19. Creutzfeldt-Jakob’s Disease
20. Cryptosporidium Parvum
21. Cyclospora Cayetanensis
22. Cytomegalovirus
23. Ebola Virus
24. E. Coli
25. Echovirus
26. Encephalitis
27. Enteroviruses
28. Epstein-Barr Virus
30. Giardia Lamblia
31. Gonorrhea
32. Granuloma Inguinale
33. Hantavirus
34. Helicobacter Pylori
35. Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT,
Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag,
HBe Ag, ALT/SGPT
36. Herpes Simplex Virus
37. Human Herpes Virus-6 (HHV-6)
38. Influenza Viruses
39. Legionella
40. Lyme Disease
41. Lymphogranuloma Venereum (LGV)
42. Malaria
43. Measles (Rubeola)
44. Meningitis
45. Microsporidium
46. Mononucleosis
47. Mumps
48. Mycoplasma
49. Norovirus
50. Papillomaviruses
51. Parvovirus B19
52. Pneumonia
53. Polyomaviruses
54. Pseudomonas Aeruginosa
55. Rabies
56. Respiratory Syncytial Virus (RSV)
57. Rhinoviruses
58. Rotavirus
59. Rubella
60. Salmonellosis
61. Septicemia
62. Shigellosis
Table of Contents (continued)
63. Staphylococcus Aureus
64. Streptococci
65. Syphilis
66. Toxoplasmosis
67. Trichomonas Vaginalis
68. Tuberculosis
69. Vibrio
70. West Nile Virus
71. Yersina
B. Instrumentation Review: Operating Characteristics,
Features and Selling Princes of Leading Infectious Disease
Automated and Semi-automated Analyzers
C. Emerging Infectious Disease Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Others
D. Personal Testing
VII. Country Analyses: Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares
- Canada
- Mexico
- USA
Table of Contents (continued)
VIII. Competitive Assessments
- Abbott
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- bioMerieux
- Bio-Rad
- Decode Genetics
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Exact Sciences
- Fujirebio
- Grifols
- Hologic
- Illumina
- Leica Biosystems
- Li-Cor Biosciences
- Myriad Genetics
- Ortho-Clinical Diagnostics
- PerkinElmer
- Proteome Sciences
- Qiagen
- Quest Diagnostics
- Quidel
- Roche
- Scienion
- Sequenom/LabCorp
- Shimadzu
- Siemens Healthineers
- Sierra Molecular
- Takara Bio
- Tecan Group
- Thermo Fisher
- Wako Chemical

List Of Tables

Canada
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Canada
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Mexico
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Mexico
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
U.S.A.
Laboratories Performing Infectious Disease Tests by
Market Segment
U.S.A.
Hospital Laboratories Performing Infectious Disease
Tests by Bed Size
U.S.A.
Commercial/Private Laboratories Performing Infectious
Disease Tests by Annual Test Volume
U.S.A.
Physician Office Laboratories Performing Infectious
Disease Tests by Practice Size
U.S.A.
All Market Segments Infectious Disease Test Volume Forecast
U.S.A.
All Market Segments Infectious Disease Test Volume by Method
U.S.A.
Hospital Laboratories Infectious Disease Test Volume Forecast
U.S.A.
Blood Banks Infectious Disease Test Volume Forecast
U.S.A.
Physician Office Laboratories Infectious Disease
Test Volume Forecast
U.S.A.
Commercial/Private Laboratories Infectious Disease
Test Volume Forecast
List of Tables (continued)
U.S.A.
Public Health Laboratories Infectious Disease Test
Volume Forecast
U.S.A.
All Market Segments Infectious Disease Diagnostics
Market Forecast
U.S.A.
Hospital Laboratories Infectious Disease Diagnostics
Market Forecast
U.S.A.
Blood Banks Infectious Disease Diagnostics Market Forecast
U.S.A.
Physician Office Laboratories Infectious Disease
Diagnostics Market Forecast
U.S.A.
Commercial/Private Laboratories Infectious Disease
Diagnostics Market Forecast
U.S.A.
Public Health Laboratories Infectious Disease
Diagnostics Market Forecast
U.S.A.
AIDS Testing Market Diagnostics Sales by Major
Supplier
U.S.A.
Adenovirus Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Campylobacter Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Candida Testing Market Diagnostics Sales by Major
Supplier
U.S.A.
Chancroid Testing Market Diagnostics Sales by Major
Supplier
U.S.A.
Chlamydia Testing Market Diagnostics Sales by Major
Supplier
List of Tables (continued)
U.S.A.
CMV Testing Market Diagnostics Sales by Major
Supplier
U.S.A.
Cryptosporidium Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Echovirus Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Enterovirus Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
EBV Testing Market Diagnostics Sales by Major
Supplier
U.S.A.
Giardia Testing Market Diagnostics Sales by Major
Supplier
U.S.A.
Gonorrhea Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Helicobacter Pylori Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Hepatitis Testing Market Diagnostics Sales by Major
Supplier
U.S.A.
Hepatitis C Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Herpes Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Influenza Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Legionella Testing Market Diagnostics Sales by
Major Supplier
List of Tables (continued)
U.S.A.
Lyme Disease Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Measles Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Meningitis Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Mononucleosis Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Mumps Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Mycoplasma Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Pneumonia Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Rabies Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
RSV Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Rotavirus Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Rubella Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Salmonella Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Septicemia Testing Market Diagnostics Sales by
Major Supplier
List of Tables (continued)
U.S.A.
Shigella Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Streptococci Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Syphilis Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Toxoplasmosis Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Tuberculosis Testing Market Diagnostics Sales by Major
Supplier
Major Companies Developing or
Marketing AIDS Tests
Major Companies Developing or
Marketing Adenovirus Tests
Major Companies Developing or
Marketing Bartonella Tests
Major Companies Developing or
Marketing Campylobacter Tests
Major Companies Developing or
Marketing Candida Tests
Major Companies Developing or
Marketing Carbapenemase Tests
Major Companies Developing or
Marketing Chlamydia Tests
Major Companies Developing or
Marketing Clostridium Tests
Major Companies Developing or
Marketing Coronavirus Tests
Major Companies Developing or
Marketing Cryptosporidium Tests
List of Tables (continued)
Major Companies Developing or
Marketing CMV Tests
Major Companies Developing or
Marketing Echovirus Tests
Major Companies Developing or
Marketing Enterovirus Tests
Major Companies Developing or
Marketing EBV Tests
Major Companies Developing or
Marketing Giardia Tests
Major Companies Developing or
Marketing Gonorrhea Tests
Major Companies Developing or
Marketing Hantavirus Tests
Major Companies Developing or
Marketing Helicobacter Pylori Tests
Major Companies Developing or
Marketing Hepatitis Tests
Major Companies Developing or
Marketing Herpes Tests
Major Companies Developing or
Marketing Influenza Tests
Major Companies Developing or
Marketing Legionella Tests
Major Companies Developing or
Marketing Lyme Disease Tests
Major Companies Developing or
Marketing Lymphogranuloma Tests
Major Companies Developing or
Marketing Malaria Tests
Major Companies Developing or
Marketing Measles Tests
Major Companies Developing or
Marketing Meningitis Tests
List of Tables (continued)
Major Companies Developing or
Marketing Microsporidium Tests
Major Companies Developing or
Marketing Mononucleosis Tests
Major Companies Developing or
Marketing Mumps Tests
Major Companies Developing or
Marketing Mycoplasma Tests
Major Companies Developing or
Marketing Norovirus Tests
Major Companies Developing or
Marketing Papilloma Virus Tests
Major Companies Developing or
Marketing Parvovirus Tests
Major Companies Developing or
Marketing Pneumonia Tests
Major Companies Developing or
Marketing RSV Tests
Major Companies Developing or
Marketing Rotavirus Tests
Major Companies Developing or
Marketing Rubella Tests
Major Companies Developing or
Marketing Salmonella Tests
Major Companies Developing or
Marketing Septicemia Tests
Major Companies Developing or
Marketing Shigella Tests
Major Companies Developing or
Marketing Staphylococci Tests
Major Companies Developing or
Marketing Streptococci Tests
Major Companies Developing or
Marketing Syphilis Tests
List of Tables (continued)
Major Companies Developing or
Marketing Toxoplasmosis Tests
Major Companies Developing or
Marketing Trichomonas Tests
Major Companies Developing or
Marketing Tuberculosis Tests
Major Companies Developing or
Marketing West Nile Tests
Major Companies Developing or
Marketing Yersinia Tests

Fill The Form For Sample Request

There is no Reviews available